NCT02498327View on ClinicalTrials.gov

The Efficacy of Venavine Intensive® on the Quality of Life in Females With Chronic Venous Insufficiency

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Venous Insufficiency
Interventions
OTHER

Gelatine Capsule

Gelatine capsules containing only the inactive ingredients of starch amyral white, di-calcium phosphate DC and magnesium stearate fine.

OTHER

Venavine Intensive®

Gelatine capsules containing 360 mg Red Vine Leaf extract, 60 mg of Horse Chestnut extract, 35 mg of Butchers Broom extract and 3,2 mg of Vitamin B6 as well as the inactive ingredients of starch amyral white, di-calcium phosphate DC and magnesium stearate fine.

Trial Locations (1)

2028

University of Johannesburg, Johannesburg

All Listed Sponsors
lead

University of Johannesburg

OTHER

NCT02498327 - The Efficacy of Venavine Intensive® on the Quality of Life in Females With Chronic Venous Insufficiency | Biotech Hunter | Biotech Hunter